Tarsons Products Limited

BSE: TARSONS543399ISIN INE144Z01023

Healthcare
Medical Equipment & Supplies
BSE Healthcare

Share price

₹310.35+12.95 (+4.35%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹374.40
52W low: ₹164.15
Off 52W high: -17.11%
1M return: -7.54%
3M return: -5.09%
6M return: +36.06%
1Y return: +7.85%
20D avg volume: 6,226
50 DMA: ₹323.19
200 DMA: ₹256.53

Key ratios Consolidated

Market cap: ₹1,651 Cr
Current price: ₹310.35
52W high / low: ₹374.40 / ₹164.15
Face value: ₹2.00
P/E: 148.83
P/B: 2.60
EPS (TTM): ₹2.09
Book value / share: ₹119.29
ROE: —
ROCE: 4.80%
Operating margin: —
Net margin: —
Debt / equity: 0.60
Net debt: ₹359.44 Cr
Interest cover: 1.97
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 168.4 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q4 FY22
Income statement
	110.24	120.93	107.89	102.33	91.36	112.69	95.68	99.25	84.80	105.72	61.79	84.94
	5.98	6.61	8.42	5.80	3.34	3.78	0.85	8.43	2.91	3.38	3.24	2.58
	116.22	127.54	116.31	108.13	94.70	116.47	96.53	107.67	87.70	109.10	65.03	87.52
	117.55	121.99	107.46	102.54	91.67	100.90	88.48	92.81	81.39	92.05	51.48	48.29
	22.19	21.93	17.89	17.35	15.81	21.88	19.58	18.29	20.28	16.34	15.34	20.03
	12.61	14.49	14.28	10.43	10.61	11.81	11.15	12.96	15.09	8.69	1.99	2.90
	21.21	20.36	19.51	17.81	17.86	16.80	16.38	16.11	16.09	15.60	9.78	8.60
	6.26	6.25	6.05	5.17	5.07	5.20	5.03	4.84	4.32	4.25	2.51	0.45
	27.02	29.08	25.04	22.48	19.94	20.03	17.41	14.03	11.03	12.33	10.06	7.24
	24.35	25.12	21.73	23.84	19.49	20.97	18.42	25.20	22.27	26.66	12.46	13.02
	-1.32	5.55	8.86	5.59	3.03	15.57	8.05	14.87	6.32	17.04	13.55	39.22
	0.00	0.22	-1.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	-1.32	5.77	7.51	5.59	3.03	15.57	8.05	14.87	6.32	17.04	13.55	39.22
	0.12	1.59	2.47	2.27	1.25	5.37	2.79	4.57	2.30	6.73	3.62	9.76
	-1.44	4.18	5.04	3.32	1.78	10.20	5.26	10.29	4.02	10.32	9.93	29.46
	-0.27	0.79	0.95	0.62	0.34	1.92	0.99	1.93	0.75	1.94	1.87	5.69
Key metrics
	31.96	41.10	38.60	33.24	28.04	40.80	30.49	33.74	21.67	33.62	26.12	46.91
	29.00%	34.00%	35.80%	32.50%	30.70%	36.20%	31.90%	34.00%	25.60%	31.80%	42.30%	55.20%
	-1.30%	3.50%	4.70%	3.20%	1.90%	9.10%	5.50%	10.40%	4.70%	9.80%	16.10%	34.70%
	—	1.30%	—	1.20%	—	2.30%	—	—	—	—	—	—
	20.70%	7.30%	12.80%	3.10%	7.70%	6.60%	54.80%	—	—	—	—	—
	-180.90%	-59.00%	-4.20%	-67.70%	-55.70%	-1.20%	-47.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY22
Income statement
	441.39	422.51	392.41	296.39	300.79
	26.81	24.17	15.96	11.47	8.47
	468.20	446.69	408.37	307.87	309.26
	449.54	423.66	363.57	247.10	174.27
	79.36	72.98	80.04	63.03	69.59
	51.81	49.81	51.02	16.25	10.52
	78.89	75.54	65.38	44.27	31.41
	23.73	22.55	19.39	10.12	4.22
	103.62	96.53	62.50	40.40	21.96
	95.04	90.18	86.86	70.11	53.78
	18.68	23.03	44.80	60.77	134.99
	-1.13	-1.13	0.00	0.00	0.00
	17.55	21.90	44.80	60.77	134.99
	6.45	7.58	15.03	18.13	34.33
	11.10	14.32	29.77	42.64	100.66
	2.09	2.69	5.60	8.01	19.46
Key metrics
	144.90	140.98	126.69	111.29	161.17
	32.83%	33.40%	32.30%	37.50%	53.60%
	2.51%	3.40%	7.60%	14.40%	33.50%
	—	4.80%	7.10%	—	—
	10.63%	7.70%	32.40%	-1.50%	—
	-59.68%	-51.90%	-30.20%	-57.60%	—
	—	-7.10	-37.47	—	—
	—	8.27	3.84	—	—
	—	0.60	0.52	—	—
	—	359.44	303.43	—	—
	—	168.4	176.7	—	—
Balance sheet
	—	1,186	1,080	—	—
	—	265.75	242.58	—	—
	—	23.19	25.13	—	—
	—	85.39	79.62	—	—
	—	129.78	126.05	—	—
	—	23.16	11.16	—	—
	—	656.80	455.12	—	—
	—	20.31	15.71	—	—
	—	264.19	175.73	—	—
	—	382.63	328.56	—	—
	—	173.10	123.69	—	—
	—	209.53	204.87	—	—
	—	634.69	630.21	—	—
Cash flow
	—	118.48	114.24	—	—
	—	-130.37	-145.49	—	—
	—	8.93	38.95	—	—
	—	125.58	151.71	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	86.15	97.16	83.99	80.51	71.28	93.04	76.16	80.12	64.85	86.64	61.79	66.32
	6.75	7.42	9.71	7.32	4.58	6.37	2.12	10.65	4.86	5.93	3.38	2.60
	92.90	104.57	93.70	87.82	75.86	99.42	78.28	90.78	69.71	92.56	65.17	68.92
	91.98	96.69	82.82	78.95	71.08	78.07	67.98	73.26	60.99	67.06	51.47	51.59
	22.19	21.93	17.89	17.35	15.81	21.88	19.59	18.29	20.28	16.34	15.34	14.64
	1.26	2.31	2.09	2.30	1.85	3.68	2.24	3.12	2.45	1.52	1.99	3.21
	12.74	12.43	11.70	11.82	11.88	11.09	11.11	10.94	10.65	10.11	9.78	9.78
	5.44	5.41	5.32	4.41	4.28	4.51	4.13	4.68	4.20	4.08	2.51	0.95
	24.56	26.70	22.65	20.17	17.75	17.48	15.61	11.96	8.96	10.21	10.06	9.71
	20.88	21.57	18.87	20.68	16.76	18.53	15.22	22.76	19.12	18.86	12.46	14.39
	0.92	7.88	10.88	8.88	4.78	21.34	10.30	17.51	8.72	25.51	13.69	17.32
	0.00	0.22	-1.35	0.00	0.00	0.00	—	—	—	—	—	—
	0.92	8.10	9.53	8.88	4.78	21.34	10.30	17.51	8.72	25.51	13.69	17.32
	0.24	2.64	2.44	2.35	1.21	5.61	2.69	4.58	2.26	6.72	3.62	4.52
	0.68	5.46	7.09	6.53	3.57	15.73	7.61	12.93	6.46	18.78	10.07	12.80
	0.13	1.03	1.33	1.23	0.67	2.96	1.43	2.43	1.21	3.53	1.89	2.41
Key metrics
	30.92	40.21	37.50	33.46	26.81	43.33	30.04	34.15	21.88	39.80	26.26	27.98
	35.90%	41.40%	44.60%	41.60%	37.60%	46.60%	39.40%	42.60%	33.70%	45.90%	42.50%	42.20%
	0.80%	5.60%	8.40%	8.10%	5.00%	16.90%	10.00%	16.10%	10.00%	21.70%	16.30%	19.30%
	—	1.50%	—	1.60%	—	3.10%	—	—	—	—	—	—
	20.90%	4.40%	10.30%	0.50%	9.90%	7.40%	23.30%	20.80%	—	—	—	—
	-81.00%	-65.30%	-6.80%	-49.50%	-44.70%	-16.20%	-24.40%	1.00%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	347.81	332.93	314.18	277.31	283.25	300.79
	31.20	29.03	24.01	14.16	11.93	8.47
	378.99	361.96	338.18	291.47	295.18	309.26
	350.44	329.54	280.31	222.10	186.46	174.27
	79.36	72.98	80.04	63.03	71.12	69.59
	7.96	8.55	11.49	9.08	9.59	10.52
	48.69	47.83	43.79	38.78	34.07	31.41
	20.58	19.43	17.52	9.95	4.47	4.22
	94.08	87.28	54.01	38.28	28.51	21.96
	82.00	77.88	75.64	62.30	54.36	53.78
	28.56	32.42	57.87	69.37	108.72	134.99
	-1.13	-1.13	0.00	—	—	—
	27.43	31.29	57.87	69.37	108.72	134.99
	7.67	8.63	15.14	18.12	28.01	34.33
	19.76	22.66	42.73	51.25	80.71	100.66
	3.72	4.26	8.03	9.63	15.17	19.46
Key metrics
	142.09	138.00	129.40	117.60	141.70	161.17
	40.85%	41.50%	41.20%	42.40%	50.00%	53.60%
	5.68%	6.80%	13.60%	18.50%	28.50%	33.50%
	—	5.80%	9.00%	—	—	—
	8.49%	6.00%	13.30%	-2.10%	-5.80%	—
	-50.40%	-47.00%	-16.60%	-36.50%	-19.80%	—
	—	-13.67	-41.86	—	—	—
	—	4.94	2.57	—	—	—
	—	0.41	0.35	—	—	—
	—	267.49	222.76	—	—	—
	—	183.5	194.7	—	—	—
Balance sheet
	—	1,102	990.63	—	—	—
	—	209.94	195.27	—	—	—
	—	6.68	7.93	—	—	—
	—	77.33	73.76	—	—	—
	—	102.86	102.65	—	—	—
	—	20.90	9.91	—	—	—
	—	654.83	453.09	—	—	—
	—	12.82	8.88	—	—	—
	—	228.33	155.15	—	—	—
	—	274.17	230.69	—	—	—
	—	149.99	117.69	—	—	—
	—	124.18	113.00	—	—	—
	—	675.59	652.39	—	—	—
Cash flow
	—	111.83	109.79	—	—	—
	—	-138.46	-51.92	—	—	—
	—	25.38	-53.96	—	—	—
	—	125.50	151.65	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +5.53%
Sales CAGR 5Y: —
Profit CAGR 3Y: -34.52%
Profit CAGR 5Y: —
Sales YoY (TTM): +8.49%
Profit YoY (TTM): -50.40%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +10.63%
Profit YoY (TTM): -59.68%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 47.32%

Quarter	September 2026	June 2026	March 2026	December 2025	September 2025	June 2025
Promoter %	47.32%	47.32%	47.32%	47.32%	47.32%	47.32%

Holder	Type	Holding	Previous	Change
SANJIVE SEHGAL	Promoter	26.98%	26.98%	0.00%
CLEAR VISION INVESTMENT HOLDINGS PTE LIMITED	Public	23.42%	23.42%	0.00%
ARYAN SEHGAL	Promoter	20.30%	20.30%	0.00%
GRACIOUS ADVISORS LLP	Public	3.15%	3.15%	0.00%
ANSHU KAPUR	Promoter Group	0.01%	0.01%	0.00%
NEETA ARORA	Promoter Group	0.01%	0.01%	0.00%
JYOTI LIKHARI	Promoter Group	0.01%	0.01%	0.00%
ANU NAGRATH	Promoter Group	0.01%	0.01%	0.00%
INAYAT HEIGHTS PRIVATE LIMITED	Promoter Group	0.00%	0.00%	0.00%
INAYAT APARTMENTS PRIVATE LIMITED	Promoter Group	0.00%	0.00%	0.00%
INAYAT PROPERTIES PRIVATE LIMITED	Promoter Group	0.00%	0.00%	0.00%
INAYAT HOMES PRIVATE LIMITED	Promoter Group	0.00%	0.00%	0.00%
ARYAN SEHGAL AND OTHERS HUF	Promoter Group	0.00%	0.00%	0.00%
INAYAT ESTATES PRIVATE LIMITED	Promoter Group	0.00%	0.00%	0.00%
SANJIVE SEHGAL AND OTHERS HUF	Promoter Group	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Poly Medicure Ltd	16,093	1,587.65	51.43	13.20%	+18.31% TTM	-12.49% TTM	-18.70%
MOLBIO DIAGNOSTICS LIMITED	15,901	1,379.80	—	—	—	—	—
Sahajanand Medical Technologies Limited	4,939	485.85	—	—	—	—	—
FISCHER MEDICAL VENTURES LIMITED	1,655	25.29	59.29	12.70%	+195.94% TTM	+371.52% TTM	-73.00%
Tarsons Products Limited	1,651	310.35	148.83	4.80%	+10.63% TTM	-59.68% TTM	+7.85%
Laxmi Dental Limited	1,036	188.30	31.98	11.50%	+13.07% TTM	+24.85% TTM	-40.71%
Hemant Surgical Industries Limited	884	608.10	—	19.50%	—	—	+109.69%
Fabtech Technologies Limited	591	133.05	16.61	11.60%	—	—	-44.16%
Prevest Denpro Limited	480	400.00	—	21.90%	—	—	-23.80%
Nureca Limited	288	301.65	60.46	3.40%	+33.66% TTM	+15.82% TTM	+17.10%
EARKART LIMITED S	161	117.00	32.59	12.10%	—	—	-48.46%
CHOKSI ASIA LIMITED S	120	210.00	23.08	18.40%	+21.40% TTM	+132.74% TTM	+97.28%
Shree Pacetronix Ltd	63	169.15	19.60	25.00%	+22.63% TTM	+208.57% TTM	-38.65%
Amkay Products Limited S	46	53.50	20.04	13.40%	—	—	+13.88%
KMS Medisurgi Limited S	44	132.80	177.07	4.80%	—	—	—
Royal Sense Limited	36	67.70	—	26.10%	—	—	-70.69%
GKB Ophthalmics Ltd.	31	62.00	5.67	9.60%	+29.95% TTM	+170.50% TTM	-9.48%
Centenial Surgical Suture Ltd. S	26	71.96	-17.99	2.60%	+6.70% TTM	+26.29% TTM	-33.37%
Transpact Enterprises Limited S	4	100.70	—	14.50%	—	—	-57.35%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

Intimation of Schedule of Investor/Analyst Conference Call to discuss the financial and operational performance for the quarter and half year ended September 30, 20264 Nov 2026 · Company Update / Analyst / Investor Meet
Tarsons Products Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve the Unaudited Standalone and ....4 Nov 2026 · Board Meeting / Board Meeting
Intimation under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026.9 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Re-appointment of Director, who was liable to retire by rotation, at the 43rd AGM of the Company.28 Sep 2026 · AGM/EGM / AGM
Submission of Voting Results and Scrutinizer''s Report of 43rd AGM of the Company held on Thursday, September 24, 2026.28 Sep 2026 · AGM/EGM / AGM
Closure of Trading Window for the quarter and half year ended September 30, 2026.24 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation of Schedule of Analyst/Institutional Investor Meeting.24 Sep 2026 · Company Update / Analyst / Investor Meet
Summary of Proceedings of the 43rd Annual General Meeting of Tarsons Products Limited.24 Sep 2026 · AGM/EGM / AGM
The Exchange has sought clarification from the company on September 22, 2026, with reference to Movement in Volume.22 Sep 2026 · Company Update / General
The Exchange has sought clarification from Tarsons Products Ltd on September 22, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited.22 Sep 2026 · Company Update / Clarification
Newspaper Publication for 43rd Annual General Meeting -Completion of dissemination of Notice and Annual Report for FY 2025-26.3 Sep 2026 · Company Update / Newspaper Publication
Regulation 36(1)(b) of SEBI Listing Regulations, letter to shareholders providing the weblink to access the Notice & Annual Report of the Company.2 Sep 2026 · Company Update / General
Business Responsibility and Sustainability Report for the financial year ended March 31, 20262 Sep 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Notice of the 43rd Annual General Meeting of the Company is scheduled to be held on Thursday, September 24, 2026, at 12:00 P.M(IST) through VC/OAVM.2 Sep 2026 · AGM/EGM / AGM
Notice of the 43rd Annual General Meeting of the Company is scheduled to be held on Thursday, September 24, 2026, at 12:00 P.M(IST) through VC/OAVM.2 Sep 2026 · AGM/EGM / AGM
Annual Report for the Financial Year ended March 31, 20262 Sep 2026 · Others / Reg. 34 (1) Annual Report
Newspaper Publication - Public Notice for conducting the 43rd Annual General Meeting through VC/OVAM.25 Aug 2026 · Company Update / Newspaper Publication
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Transcript of Earnings Conference Call for the quarter ended June 30, 202617 Aug 2026 · Company Update / Earnings Call Transcript
Intimation of Audio Recording of Conference Call11 Aug 2026 · Company Update / Analyst / Investor Meet
Newspaper Publication of Financial Results for the quarter ended June 30, 202611 Aug 2026 · Company Update / Newspaper Publication
Investor Presentation for the quarter ended June 30, 2026.11 Aug 2026 · Company Update / Investor Presentation
Update regarding the Finalization of the date of 43rd Annual General Meeting of the Company.10 Aug 2026 · Company Update / General
Board Meeting held on Monday, August 10, 2026 to approve the Unaudited Standalone & Consolidated Financial Results of the Company for the Quarter ended June 30, 2026.10 Aug 2026 · Result / Financial Results
Outcome of the Board meeting held on Monday, August 10, 2026 to approve the Unaudited Standalone & Consolidated Financial Results of the Company for the quarter ended June 30, 202610 Aug 2026 · Board Meeting / Outcome of Board Meeting
Intimation of Schedule of Analyst/Institutional Investor Meeting(s) to be held on August 13, 2026.7 Aug 2026 · Company Update / Analyst / Investor Meet
Intimation of Schedule of Investor/Analyst Conference Call to discuss the financial and operational performance for the quarter ended June 30, 20264 Aug 2026 · Company Update / Analyst / Investor Meet
Tarsons Products Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve the Unaudited Standalone and ....4 Aug 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74 (5) of the SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2026.9 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window for the quarter ended June 30, 202623 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Reply on Clarification sought on significant movement in price of Tarsons Products Limited.18 Jun 2026 · Company Update / General
The Exchange has sought clarification from Tarsons Products Ltd on June 18, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....18 Jun 2026 · Company Update / Clarification
Reply on Clarification sought for spurt on volume of Tarsons Products Limited.17 Jun 2026 · Company Update / General
The Exchange has sought clarification from Tarsons Products Ltd on June 17, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited.17 Jun 2026 · Company Update / Clarification
Intimation of resignation of Senior Management Personnel of the Company - Mr. Subhra Shankar Bose, Human Resource Head.15 Jun 2026 · Company Update / Change in Management
Intimation of Schedule of Analyst/Institutional Investor Meeting(s)6 Jun 2026 · Company Update / Analyst / Investor Meet
Intimation of Schedule of Analyst/Institutional Investor Meeting(s)6 Jun 2026 · Company Update / Analyst / Investor Meet
Intimation under Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.3 Jun 2026 · Company Update / General
Transcript of Earning Call for the quarter and financial year ended March 31, 20261 Jun 2026 · Company Update / Earnings Call Transcript
Intimation of Audio Recording of Conference Call to discuss the financial performance/audited Financial Results (Consolidated & Standalone) of the Company for the quarter and financial ....25 May 2026 · Company Update / Analyst / Investor Meet
Investor Presentation for the Quarter and Financial Year ended March 31, 202623 May 2026 · Company Update / Investor Presentation

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 2.0000	20 Sep 2024	—	—

Board meetings

10 Aug 2026 Board Meeting - Financial Results